Dr. Jane Smith, MD, PhD
Chief Medical ReviewerDr. Smith completed her MD at Johns Hopkins and a PhD in Biochemistry at Stanford, with her doctoral research focused on telomerase regulation in human somatic cells. She has practised internal and preventive medicine for 14 years, with a clinical focus on longevity and metabolic optimisation. She joined BiohackingHub as Chief Medical Reviewer in 2025, responsible for ensuring all substance profiles and clinical protocols reflect current peer-reviewed evidence.
Credentials & Qualifications
- MD — Johns Hopkins School of Medicine
- PhD Biochemistry — Stanford University
- Board Certified: Internal Medicine (ABIM)
- Fellow, American College of Preventive Medicine
Selected Publications
Telomere dynamics in response to NAD+ precursor supplementation: a 24-week prospective cohort
Aging (Albany NY)·2024
Peptide bioregulators in clinical longevity medicine: current evidence and protocol frameworks
Journal of Gerontology & Geriatric Medicine·2023
Safety and efficacy of low-dose methylene blue in age-related cognitive decline: a pilot RCT
Frontiers in Aging Neuroscience·2023
Recent Reviewed Content
The Biohacker's Blood Panel: 40 Biomarkers Worth Tracking
Mar 4, 2026 · Oxford 4
Deep Sleep Protocols: DSIP, Glycine, and the Architecture of Perfect Sleep
Mar 6, 2026 · Oxford 2b
The Mitochondrial Synergy: Why SS-31 Must Precede MOTS-c for Maximum Effect
Mar 14, 2026 · Oxford 4
PT-141: The Biochemistry of Libido and Sexual Health
Mar 18, 2026 · Oxford 1b
Safety and Biohacking Ethics: How to Read a COA and Not Buy Chalk
Mar 20, 2026 · Oxford 5
SS-31 (Elamipretide): Reversing Mitochondrial Aging at the Inner Membrane
Mar 23, 2026 · Oxford 2b
Specialisations
Reviewed Substances
Member since
January 2025